Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL.
作者信息
He Xiaoyuan, Xiao Xia, Li Qing, Jiang Yanyu, Cao Yaqing, Sun Rui, Jin Xin, Yuan Ting, Meng Juanxia, Ma Li, Lu Wenyi, Lyu Cuicui, Liu Kaiqi, Zhao Mingfeng
机构信息
Nankai University School of Medicine, Tianjin, PR China.
Department of hematology, Tianjin First Central Hospital, No. 24 Fu Kang Road, Tianjin, PR China.
出版信息
Leukemia. 2019 Aug;33(8):2102-2104. doi: 10.1038/s41375-019-0437-5. Epub 2019 Mar 7.
Abstract
摘要
Zotero 插件